Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
www.ahrq.gov

Table 5_2_2.2a
Adult patients with HIV and CD4 count <200 who received Pneumocystis pneumonia (PCP) prophylaxis,a by race/ethnicity, United States, 2005
Population group Total Non-Hispanic, White Non-Hispanic, Black Hispanic Other
Percent SE Percent SE Percent SE Percent SE Percent SE
Total 90.6 0.5 91.1 1.0 90.6 0.7 90.3 1.1 90.7 4.5
Age 18–44 90.8 0.7 91.1 1.3 90.8 1.0 91.2 1.4 * *
45 and over 90.2 0.8 91.1 1.6 90.3 1.2 88.6 2.1 * *
Gender Male 91.9 0.6 91.8 1.0 92.6 0.8 91.0 1.3 91.7 4.7
Female 86.5 1.2 84.9 3.9 86.3 1.5 87.4 2.6 * *
Health insurance Private 90.6 1.7 86.9 3.3 92.7 2.2 93.3 4.6 * *
Medicaid/dual eligible 90.0 0.9 91.4 2.1 90.4 1.1 88.4 1.9 * *
Medicare 93.3 1.1 94.6 1.7 93.3 1.7 90.3 3.1 * *
Other/uninsured 93.3 1.1 95.1 1.7 92.2 1.7 94.4 1.9 * *

a For HIV patients having at least two CD4 tests < 200 during the year.

* - Data do not meet the criteria for statistical reliability, data quality, or confidentiality.

Key: PCP: Pneumocystis pneumonia; SE: standard error.

Source: Agency for Healthcare Research and Quality, Center for Delivery, Organization and Markets, HIV Research Network.

 

AHRQ Advancing Excellence in Health Care